Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes and Quality of Life After Transarterial Radioembolization With Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

NCT04315883 is registered in ClinicalTrials.gov with Nemours Children's Clinic as lead sponsor.

NCT NCT04315883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes and Quality of Life After Transarterial Radioembolization With Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
Lead sponsor
Nemours Children's Clinic
Phase
Observational
Overall status
Terminated
Start date
February 11, 2021
Completion date
March 28, 2024
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatoblastoma, hepatocellular carcinoma, liver tumors, pediatric liver cancer, rhabdoid tumor of liver, undifferentiated (embryonal) sarcoma of the liver